BioresearchOnline

BioresearchOnline

@Bioresearch Erie, PA
Bioresearch Online provides information on emerging technologies, manufacturing, and development trends in large molecule research and Biopharmaceuticals.
Text follow Bioresearch to 40404 in the United States
»
BioresearchOnline
Good Timing: NIST/CU Collaboration Adds Timing Capability To Living Cell Sensors
»
BioresearchOnline
Last day at DDP starting with uncovering he next best technology with humanitarian/inventor Marc Koska
»
BioresearchOnline
Biosimilars...threat or opportunity?
»
BioresearchOnline
Mark McClellan speaks on history reallyaffect real reform in healthcare--
»
BioresearchOnline
Getting ready for the morning kickoff at with Lee Shorter -- Director at
»
BioresearchOnline
Getting to know more about biologics at with and
»
BioresearchOnline
Getting ready to attend Drug Delivery Partnerships. Anyone else here this week?
»
BioresearchOnline
Want to know who has highest medical standard 4 safely & securely shipping frozen product?
»
BioresearchOnline
Today's Must-Read: New Single-Use Devices: Trends And Demands Single-Use Biomanufacturing Devices In High Demand ...
»
BioresearchOnline
JPT Peptide Technologies, IUCT And LEITAT Collaborate On Development Of Novel Biofocused Anticancer Therapies ...
»
BioresearchOnline
Why And Nix Trial Of Dimebon In 's Disease
»
BioresearchOnline
Astex Announces Early Transfer Of Epigenetics Project To
»
BioresearchOnline
DFH Pharma To Collaborate With National Cancer Institute To Develop Second-Generation HIV Maturation Inhibitor Drugs
»
BioresearchOnline
2012 Announces New Short Courses
»
BioresearchOnline
Drug Duo May Help Fight Aggressive Form of Breast
»
BioresearchOnline
More Known About Proteins That Cause Autoimmune Diseases
»
BioresearchOnline
Will we have an effective Alzheimer's treatment by 2025?
»
BioresearchOnline
FOX NEWS: FDA - J&J delayed reporting insulin pump problems
»
BioresearchOnline
See Bioresearch Online's first "Single-Use Insights" Newsletter
»
BioresearchOnline
Bristol-Myers Squibb Signs $2.5B Deal To Acquire Inhibitex, Hep C Drug Development